BMO Capital Downgrades Clorox (CLX) to Market Perform
More News related to CLX
- Clorox Announces Oct. 31, 2008, Webcast of First-Quarter Results
- Clorox Earns Third Consecutive Top Rating on Human Rights Campaign's Corporate Equality Index
- Jacqueline P. Kane, Nina G. Vaca Appointed to the Comerica Incorporated Board of Directors
- Clorox Declares Regular Quarterly Dividend
- BeaconEquity.com Issues Trade Alerts on Market Movers: SPNG, DAR, CLX, ECL, PG, CL
More News related to Downgrades
- Canaccord Adams Downgrades Freeport-McMoRan (FCX) to Sell, Slashes Price Target
- Jefferies Downgrades Advanced Medical Optics (EYE) to Underperform
- Susquehanna Downgrades Isle of Capri Casinos (ISLE) to Neutral
- Susquehanna Downgrades Boyd Gaming Corporation (BYD) to Neutral
- Susquehanna Downgrades MGM MIRAGE (MGM) to Neutral
BMO Capital downgrades Clorox (NYSE: CLX) from Outperorm to Market Perform with a $61 price target.
The Clorox Company manufactures and markets a range of consumer products, including bleaches, stain removers, sanitizing sprays and others.
Related Categories
DowngradesStocks Mentioned
-0.46Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
